Henderson, Nevada – June 16, 2022 – United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement of the SEC investigation initially reported by the Company in its Annual Report on Form 10-K for the year ended December 31, 2021. UHP has agreed with the Securities and Exchange Commission (the Commission) to […]
News
United Health Products Provides Regulatory Update
Henderson, Nevada – May 18, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process. Regulatory Review As previously disclosed, on April 20, 2022, UHP delivered to the U.S. Food & Drug Administration (FDA) a supplemented and e-formatted Premarket Approval (PMA) response for its HemoStyp™ hemostatic […]
Support for Ukraine
In an effort to support the people of Ukraine and those working to defend the country against the Russian invasion, UHP donated 10,000 units of its HemoStyp® hemostatic gauze to aid with much needed civilian and military medical care. United Health Products dropped off the final shipment of 10,000 units of HemoStyp gauze with AFYA, […]
United Health Products Provides Regulatory and Business Update
Henderson, Nevada – April 27, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process and other matters. Regulatory Review As previously disclosed in the company’s Form 10-K, the U.S. Food & Drug Administration (FDA) requested in late January 2022 that i) the responses submitted by UHP […]
United Health Products Provides Regulatory and Business Update
Henderson, Nevada – April 1, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its regulatory process, business condition, and other matters. Regulatory Approvals Following the submission in October, 2021 of a response to the FDA’s questions and comments on its Premarket Approval (PMA) application, UHP and the FDA held […]
United Health Products Provides Regulatory Status Update
Henderson, Nevada – December 22, 2021 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the status of its application to the Food & Drug Administration (FDA) for Pre-market Approval (PMA) of its HemoStyp™ hemostatic gauze. On December 21st, the FDA informed UHP that its review of the PMA application is ongoing […]